| Literature DB >> 30537998 |
Margita Držaić1, Ingrid Kummer1, Iva Mucalo2, Andreia Bruno3, Maja Ortner Hadžiabdić4.
Abstract
BACKGROUND: Competency frameworks that prompt personal and professional development have become an important component of lifelong learning; they are driven by healthcare professionals' need for development and professional recognition. This study aimed to evaluate the self-assessed competencies of community pharmacist-preceptors by using Croatian Competency Framework (CCF) and to identify competencies to be improved. The secondary aim was to explore the association between community pharmacists' characteristics (i.e. age, education etc.) and self-assessed competency performance.Entities:
Keywords: Community pharmacy; Competency; Continuing professional development; Croatian competency framework; Pharmacist-preceptor
Mesh:
Year: 2018 PMID: 30537998 PMCID: PMC6288869 DOI: 10.1186/s12909-018-1413-x
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Demographic Characteristics of Community Pharmacists
| Variable | n | % | |
|---|---|---|---|
| Gender | Male | 19 | 8.5 |
| Female | 204 | 91.5 | |
| Age (years) | median (range) | 41 (27–65) | |
| <35 | 59 | 26.5 | |
| 36–45 | 96 | 43.0 | |
| 46–55 | 45 | 20.2 | |
| >56 | 23 | 10.3 | |
| Work experience in community pharmacy (years) | median (range) | 14 (2–40) | |
| < 10 | 71 | 31.8 | |
| 11–20 | 95 | 42.6 | |
| 21–30 | 43 | 19.3 | |
| 31–40 | 14 | 6.3 | |
| Location of pharmacy | City of Zagreb | 103 | 46.2 |
| rest of the Croatia | 120 | 53.8 | |
| Education | Master degree-level pharmacists | 199 | 89.2 |
| Master degree-level pharmacists with additional postgraduate education | 24 | 10.8 | |
| Type of community pharmacy | single pharmacy | 16 | 7.2 |
| pharmacy institution | 207 | 92.8 | |
| Pharmacy ownership | single private pharmacy | 8 | 3.6 |
| private pharmacy institution | 123 | 55.2 | |
| state-owned pharmacy institution | 84 | 37.7 | |
| pharmacy under private lease | 8 | 3.6 | |
| Size of pharmacy chain | single pharmacy | 16 | 7.2 |
| medium (2–10 pharmacies) | 71 | 31.8 | |
| large (> 10 pharmacies) | 136 | 61.0 | |
Self-Assessed Competencies’ Mean Scores
| Cluster and Competency Code | Cluster | Competency | Mean Score | SDa |
|---|---|---|---|---|
| KK1 | Pharmaceutical Public Health Competencies | 2.75 | 0.769 | |
| K1.1. | Health promotion | 2.75 | 0.769 | |
| KK2 | Pharmaceutical Care Competencies | 3.29 | 0.375 | |
| K2.1. | Assessment of medicines and medical devices | 3.41 | 0.513 | |
| K2.2. | Compounding of magistral and galenic preparations | 3.63 | 0.436 | |
| K2.3. | Dispensing medicines and medical devices | 3.68 | 0.274 | |
| K2.4. | Patient consultation | 3.13 | 0.529 | |
| K2.5. | Assurance of safe medicines use | 2.62 | 0.685 | |
| KK3 | Organization and Management Competencies | 3.64 | 0.336 | |
| K3.1. | Organization | 3.71 | 0.470 | |
| K3.2. | Finance management | 3.69 | 0.483 | |
| K3.3. | Human resources management | 3.36 | 0.692 | |
| K3.4. | Workplace management | 3.70 | 0.403 | |
| K3.5. | Procurement and supply chain management | 3.74 | 0.272 | |
| KK4 | Personal and Professional Competencies | 3.41 | 0.405 | |
| K4.1. | Communication skills | 3.70 | 0.397 | |
| K4.2. | Continuing Professional Development (CPD) | 3.34 | 0.554 | |
| K4.3. | Legal and regulatory practice | 3.08 | 0.682 | |
| K4.4. | Professional and ethical practice | 3.77 | 0.393 | |
| K4.5. | Improvement of service and quality assurance | 3.03 | 0.751 | |
| K4.6. | Personal development | 3.54 | 0.537 |
aSD standard deviation
Group Differences in Cluster/Competency Self-Assessed Mean Scores
| Cluster/Competency | Age Group | Education | Location of Pharmacy | Size of Pharmacy Chain | |||||
|---|---|---|---|---|---|---|---|---|---|
| ≤35 years | 36–50 years | > 50 years | MPharm | MPharm with additional postgraduate education | Zagreb | rest of Croatia | ≤10 pharmacies | > 10 pharmacies | |
| Pharmaceutical Public Health Competencies | 2.78 | 2.73 | 2.78 | 2.71* | 3.12 | 2.77 | 2.74 | 2.70 | 2.79 |
| Health promotion | 2.78 | 2.73 | 2.78 | 2.71* | 3.12 | 2.77 | 2.74 | 2.70 | 2.79 |
| Pharmaceutical Care Competencies | 3.38 | 3.25 | 3.29 | 3.29 | 3.37 | 3.33 | 3.27 | 3.24 | 3.33 |
| Assessment of medicines and medical devices | 3.48 | 3.39 | 3.40 | 3.40 | 3.56 | 3.44 | 3.39 | 3.38 | 3.44 |
| Compounding of magistral and galenic preparations | 3.66 | 3.62 | 3.64 | 3.62 | 3.71 | 3.70* | 3.57 | 3.521 | 3.70*** |
| Dispensing medicines and medical devices | 3.72 | 3.66 | 3.68 | 3.68 | 3.73 | 3.68 | 3.68 | 3.64 | 3.71 |
| Patient consultation | 3.20 | 3.09 | 3.13 | 3.14 | 3.09 | 3.13 | 3.13 | 3.12 | 3.14 |
| Assurance of safe medicines use | 2.85## | 2.51## | 2.61 | 2.60 | 2.77 | 2.68 | 2.58 | 2.54 | 2.67 |
| Organization and Management Competencies | 3.62 | 3.67 | 3.61 | 3.64 | 3.68 | 3.64 | 3.65 | 3.62 | 3.66 |
| Organization | 3.69 | 3.72 | 3.70 | 3.66 | 3.83 | 3.67 | 3.74 | 3.77 | 3.67 |
| Finance management | 3.61 | 3.75 | 3.62 | 3.67 | 3.80 | 3.67 | 3.67 | 3.65 | 3.71 |
| Human resources management | 3.31 | 3.39 | 3.35 | 3.36 | 3.33 | 3.35 | 3.37 | 3.30 | 3.40 |
| Workplace management | 3.69 | 3.71 | 3.67 | 3.70 | 3.70 | 3.72 | 3.68 | 3.65 | 3.73 |
| Procurement and supply chain management | 3.75 | 3.76 | 3.69 | 3.74 | 3.75 | 3.75 | 3.74 | 3.72 | 3.76 |
| Personal and Professional Competencies | 3.47 | 3.38 | 3.41 | 3.64 | 3.68 | 3.44 | 3.38 | 3.35 | 3.45 |
| Communication skills | 3.71 | 3.71 | 3.69 | 3.70 | 3.69 | 3.70 | 3.70 | 3.65 | 3.74 |
| Continuing Professional Development (CPD) | 3.40 | 3.30 | 3.37 | 3.32 | 3.44 | 3.44** | 3.25 | 3.23 | 3.40* |
| Legal and regulatory practice | 3.06 | 3.06 | 3.17 | 3.09 | 3.04 | 3.09 | 3.08 | 3.01 | 3.13 |
| Professional and ethical practice | 3.82 | 3.74 | 3.75 | 3.76 | 3.84 | 3.79 | 3.74 | 3.77 | 3.76 |
| Improvement of service and quality assurance | 3.12 | 2.99 | 3.00 | 3.03 | 2.98 | 3.01 | 3.04 | 2.97 | 3.06 |
| Personal development | 3.71# | 3.48# | 3.47 | 3.53 | 3.58 | 3.61 | 3.47 | 3.47 | 3.58 |
- difference is statistically significant at the p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.005 (***) level (exact, 2-tailed)
- difference is statistically significant at the p ≤ 0,05 (#) and p ≤ 0,01 (##) (One-way ANOVA)